Yorong, Lilibeth M.
HRN: 21-73-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
CEFTRIAXONE 1G (VIAL)
08/12/2022
08/18/2022
IV
2g
OD
Typhoid
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes